CN Patent

CN119998297A — (3S,7S,10R,13R)-13-苄基-20-氟-7-异丁基-N-(2-(3-甲氧基-1,2,4-噁二唑-5-基)乙基)-6,9-二甲基-1,5,8,11-四氧代-10-(2,2,2-三氟乙基)-1,2,3,4,5,6,7,8,9,10,11,12,13,14-十四氢-[1]氧杂[4,7,10,14]四氮杂环十七烷并[16,17-f]喹啉-3-甲酰胺的晶型

Assigned to Actelion Pharmaceuticals Ltd · Expires 2025-05-13 · 1y expired

What this patent protects

本发明涉及(3S,7S,10R,13R)‑13‑苄基‑20‑氟‑7‑异丁基‑N‑(2‑(3‑甲氧基‑1,2,4‑噁二唑‑5‑基)乙基)‑6,9‑二甲基‑1,5,8,11‑四氧代‑10‑(2,2,2‑三氟乙基)‑1,2,3,4,5,6,7,8,9,10,11,12,13,14‑十四氢‑[1]氧杂[4,7,10,14]四氮杂环十七烷并[16,17‑f]喹啉‑3‑甲酰胺的晶型；其制备方法、含有这种晶型的医药组合物、从这种晶型制备的医药组合物、及其用作药物，尤其是用作CFTR调节剂的用途。

USPTO Abstract

本发明涉及(3S,7S,10R,13R)‑13‑苄基‑20‑氟‑7‑异丁基‑N‑(2‑(3‑甲氧基‑1,2,4‑噁二唑‑5‑基)乙基)‑6,9‑二甲基‑1,5,8,11‑四氧代‑10‑(2,2,2‑三氟乙基)‑1,2,3,4,5,6,7,8,9,10,11,12,13,14‑十四氢‑[1]氧杂[4,7,10,14]四氮杂环十七烷并[16,17‑f]喹啉‑3‑甲酰胺的晶型；其制备方法、含有这种晶型的医药组合物、从这种晶型制备的医药组合物、及其用作药物，尤其是用作CFTR调节剂的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN119998297A
Jurisdiction
CN
Classification
—
Expires
2025-05-13
Drug substance claim
No
Drug product claim
No
Assignee
Actelion Pharmaceuticals Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.